Skip to main content

Post-IPO Equity Companies in Boston

Explore 24 post-ipo equity startups based in Boston, United States. Access verified founder contact information and fundraising data.

Total Companies
24
Total Funding
$2.7B
Avg Funding
$112.5M
Industries
9

Export 24 Post-IPO Equity Companies in Boston

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$250.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biopharma
$100.0M
raised

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Financial Services
$260.1M
raised

Flywire is a payments enablement and software company that simplifies complex payments for its clients and their customers.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$120.0M
raised

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$60.0M
raised

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 24 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$175.0M
raised

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$50.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$100.0M
raised

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 24 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Artificial Intelligence (AI)
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Health Care
$10.5M
raised

CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$25.0M
raised

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$40.0M
raised

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 24 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$15.0M
raised

Zapata Quantum is a quantum software company that offers computing solutions for industrial and commercial use.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Aerospace
$80.0M
raised

Merlin Labs develops hardware and software solutions that deliver the capability for aircraft to fly useful missions autonomously.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$350.0M
raised

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$125.0M
raised

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Delivery
$4.3M
raised

Toast is a point-of-sale and restaurant management platform designed for businesses in the food service and hospitality industry.

Jan 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 24 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biotechnology
$9.3M
raised

MetaVia is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$143.8M
raised

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$101.0M
raised

908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.

Nov 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$450.0M
raised

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Equity Startups in Boston?

Get verified founder emails, funding details, and company data for 24 post-ipo equity companies in Boston.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked